I see the childish "my stock is better than your stock" theme still runs strongly on these threads. It should be "my investment less crap than yours" for some of the long term bitter CYP/MSB rivals on here:
There is ample room for both MSc's and IPSC's in the future regenerative medical sphere ladies and gents. The more treatments the better for those patients with unmet needs like srGVHD. Some of us are quite willingly invested in both companies (and other stem cell companies) and can see the synergies between the two doing well in advancing trials and the science generally along with other stem cell advancements and applications:
https://www.medpagetoday.com/spotlight/myelofibrosis/110260
"Allogeneic stem cell transplant is the only treatment that has the potential to cure myelofibrosis.
"It's very important to include stem cell transplant in 2024 -- and beyond -- in every conversation," said Naveen Pemmaraju, MD, of the University of Texas MD Anderson Cancer Center in Houston."
I see the childish "my stock is better than your stock" theme...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $1.233B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.11 | $1.05 | $5.002M | 4.632M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5697 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
-0.010 ( 0.10 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.11 | $1.06 | 1181223 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| MSB (ASX) Chart |